More than 100 million people in the US experience chronic pain. In Europe, the prevalence of chronic pain is between 25% and 35%. Pain-related disability represents a significant and costly liability to patients and employers.
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the worldwide TENS, neurostimulators, implantable analgesia infusion pumps, and external analgesia infusion pumps markets.
The global market for pain management devices totaled more than $3.2bn in 2016, and is expected to climb at a rate of 4.7% over the forecast period; markets covered by this analysis include the US, Europe, and ROW.
Key Topics Covered:
Executive Summary i. Pain prevalence ii. Global pain management devices market a. Selected market drivers and limiters b. TENS segment c. SCS segment d. Analgesia infusion pumps and accessories segment e. Market leaders f. Emerging competition
1. Pain Management Overview 1.1 Pain classification 1.1.1 Nociceptive and neuropathic pain 1.1.2 Acute and chronic pain 1.1.3 Pain severity 1.2 Treatment guidelines 1.3 Effects of the opioid epidemic on pain management devices 1.4 Alternative therapy options 1.5 Bibliography